David Lutton, MD
Orthopaedic Surgery · Washington, DCNPI 1770747230
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Arthrex accounts for 87.4% of it on its own, with 23 other manufacturers making up the rest. 2025 is the largest year on record at $142,693, 4.3 times the $33,067 reported in 2019. Among orthopaedic surgery clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 659 payments — averaging $569.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$328K
- Avanos Medical$22K
- Restor3d, Inc.$11K
- Supreme Orthopedic Systems, LLC$5K
- Stryker$5K
- Novartis$2K
- plus $2K from 18 others
Across 1 payment — averaging $450.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arthrex$450
Across 1 payment — averaging $7834.43 each. An ownership or investment interest held by the physician or an immediate family member.
- Restor3d, Inc.$8K
What the payments were for
- Consulting fees$110,91730%
- Speaking & faculty fees$213,43757%
- Travel & lodging$31,9979%
- Food & beverage$14,2564%
- Education$4,4801%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 473 | $327,768 |
| Avanos Medical | 14 | $21,667 |
| Restor3d, Inc. | 17 | $10,780 |
| Supreme Orthopedic Systems, LLC | 51 | $5,408 |
| Stryker | 51 | $5,127 |
| Novartis | 1 | $1,938 |
| Pinnacle, Inc | 2 | $928 |
| Ferring Pharmaceuticals Inc. | 14 | $300 |
| Zimmer Biomet | 4 | $253 |
| Fidia Pharma USA Inc. | 7 | $159 |
| Smith+Nephew | 5 | $151 |
| KCI USA, Inc. | 1 | $125 |
| Amgen | 5 | $93 |
| Exactech, Inc. | 1 | $81 |
| Encore Medical, LP | 1 | $72 |
| Pacira Pharmaceuticals Incorporated | 2 | $45 |
| Johnson & Johnson | 2 | $43 |
| Stability Biologics, LLC | 1 | $29 |
| Trevena, Inc. | 2 | $27 |
| Bioventus LLC | 1 | $21 |
| ERMI LLC | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Medartis Inc. | 1 | $17 |
| Orthofix Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ON-Q$21,318
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$2,443
- COSENTYX$1,938
- ARTHROPLASTY IMPLANTS SHOULDER ARTHROPLASTY & FRACTURE UNIVERS$1,095
- AEQUALIS PERFORM REVERSED$858
- ARTHROPLASTY IMPLANTS SHOULDER ARTHROPLASTY & FRACTURE REVERS$675
- ARTHROPLASTY INSTRUMENTS SHOULDER ARTHROPLASTY & FRACTURE VIP TECHNOLOGY$420
- ARTHROPLASTY IMPLANTS REVERS TOTAL SHOULDER REVERS$420
- AEQUALIS ASCEND FLEX$330
- AEQUALIS FLEX REVIVE$169
- AEQUALIS PERFORM$154
- REUNION$148
- ON-Q* PUMP AND ACCESSORIES$138
- ARTHROPLASTY IMPLANTS ANATOMIC TOTAL SHOULDER ECLIPSE$127
- OTHER OTHER OTHER OTHER$125
- PREVENA$125
- ALPHAVENT$111
- KNOTILUS ANCHOR, 3.5MM$111
- ICONIX$111
- DRI-LOK$111
How this compares
$375,086 in reported general payments places this provider in the 90th percentile of 46 orthopaedic surgery providers in District of Columbia.
See all orthopaedic surgery providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 31 | $779 |
| Ondansetron OdtOndansetron | 71 | $571 |
| Oxycodone Hcl | 72 | $338 |
| Meloxicam | 94 | $292 |
| Amoxicillin | 123 | $286 |
| Cyclobenzaprine Hcl | 26 | $135 |
| Gabapentin | 14 | $119 |
| Tramadol Hcl | 26 | $102 |
| Methylprednisolone | 11 | $59 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Washington
- Akhil KhannaWashington$2.1M
- Seyed KalantarWashington$886K
- Scott FaucettWashington$610K
- Savyasachi ThakkarWashington$216K
- Joseph FergusonWashington$84K
- Robert SterlingWashington$38K
- Ryan MurrayWashington$32K
- Robert HenshawWashington$24K
- Sandesh RaoWashington$21K
- James DebritzWashington$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.